Assessing the usefulness of Systane COMPLETE eye drops in reducing dry eye problems
- Conditions
- Health Condition 1: H048- Other disorders of lacrimal system
- Registration Number
- CTRI/2024/02/063319
- Lead Sponsor
- Alcon Research, Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Subjects = 18years of age both gender
2. Subjects with known case of dry eye disease
3. Best Corrected Visual Acuity (BCVA) of 6/24 [Log MAR equivalent (0.6)] or better
4. Ocular Surface Disease Index (OSDI) : 13 - 33
5. Tear film break-up time (TBUT) = 10 seconds
6. Schirmer tear test (without anesthesia) = 10mm / 5min
7. MGD Score > 20
8. Normal lid position and closure
9. Willingness to sign written informed consent document
1. Any ocular condition that, in the opinion of the Investigator, could affect study parameters. This includes active ocular infection, ocular inflammation, ocular trauma, blepharitis, or, any other condition as deemed by the Investigator.
2. Unwilling to refrain from contact lens use for the entire duration of this study.
3. History of any other ocular surgical procedure within 3 months.
4. Subject with known allergy or hypersensitivity to the components of the formulation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method